TrimRX - Telehealth Weight Management - CPS (US)
$187.50 CPLactive✓ verified live 6h ago
MaxBounty · Health & Wellness / General Wellness · US · live 55 days
Model this payoutPrefills the fixed conversion payout; your traffic assumptions stay in your browser.
Run this offer — join MaxBounty →
Should you run this?
- 📊 Payout vs its vertical: beats 98% of the 3665 live Health & Fitness offers we track (vertical median $26.28).
- 🛡️ Stability: Payout unchanged since we started tracking it 55 days ago.
Payout history
🔒 1 older event is hidden — create a free account to see this offer's full payout history.
Description
TrimRX is a streamlined telehealth platform providing medically supervised access to GLP-1 weight-management medications, including Semaglutide and Tirzepatide, via a 3-minute online assessment.
Converts on a completed purchase of a monthly weight-management program.
Targeting: US-based adults (Ages 25-65+) struggling with obesity or weight-related health issues, specifically those seeking accessible GLP-1 prescriptions and medically managed weight loss.
Restrictions: No incentivized traffic, brand bidding, or misleading medical claims; all creative must adhere to US telehealth and pharmaceutical advertising guidelines.
Creatives to be made for approval
Converts on a completed purchase of a monthly weight-management program.
Targeting: US-based adults (Ages 25-65+) struggling with obesity or weight-related health issues, specifically those seeking accessible GLP-1 prescriptions and medically managed weight loss.
Restrictions: No incentivized traffic, brand bidding, or misleading medical claims; all creative must adhere to US telehealth and pharmaceutical advertising guidelines.
Creatives to be made for approval
Change log (1 events)
🔒 1 older event is hidden — create a free account to see this offer's full payout history.
No change events recorded yet.
Reviews (0)
No reviews yet — be the first to share your experience.
Log in or create a free account to review this offer.
Payout looks wrong or a link is dead? Report a problem with this offer — we check it against the source.